Gold, L.S., Weiss, J.S., Green, L., Kircik, L., Miller, L., Jacobson, A. and Harris, S. 2020. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients with Baseline Body Surface Area of 6 -12%. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s37. DOI:https://doi.org/10.25251/skin.4.supp.37.